ePrivacy and GPDR Cookie Consent by TermsFeed Generator

DOXIPROCT PLUS

40MG/G+20MG/G+0,25MG/G RCT UNG 20G

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 08.11.2021
Cessation of marketing 24.06.2015 0200934

All reports are available in the Overview.

Back to list